Distant diabetes care: what can the patient, nurse and patient do

Czech version

Authors: František Saudek; Klára Picková
Authors‘ workplace: Centrum diabetologie, Institut klinické a experimentální medicíny, Praha
Published in: Vnitř Lék 2020; 66(3): 107-111
Category:

Overview

Due to the spread of new coronavirus disease, COVID-19, social interactions between people have been significantly reduced. In healthcare, outpatient care is a high-risk frontline of infection transmission in both patients and healthcare professionals. The presence of routine digital communication, remote data management and the availability of glucose monitoring and insulin delivery devices have given diabetology a certain advantage in this situation. However, the potential of these modalities has not been fully utilized so far. We provide an overview of practical methods of distance patient management, which can be used in most diabetes outpatient clinics without any difficult adjustments or additional investments. This approach can be used in different patients according to their treatment strategies and individual abilities.

Keywords:

diabetes – Telemedicine – COVID-19 – distant patient care – e-health

Sources

1. Zhu N, Zhang D, Wang W, et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382 : 727–733.

2. Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA.

3. Chen N, Zhou M, Dong X, et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 : 507–513

4. Huang C, Wang Y, Li X, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 : 497–506.

5. Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS -CoV-2. J Endocrinol Invest.

6. Guan WJ, Liang WH, Zhao Y, et al. (2020) Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J.

7. společnost Čd Standardy a doporučení. Available from https://www.diab.cz/standardy

8. Available from www.ikem.cz/cs/centrum -diabetologie/edukacni -materialy/a-3602

9. (online) Čsú (2019) Používání mobilního telefonu a internetu na mobilním telefonu: Využívání informačních a komunikačních technologií v domácnostech a mezi jednotlivci. Available from https://www.czso.cz/csu/czso/5-komunikace -na -internetu

10. Bergenstal RM, Beck RW, Close KL, et al. (2018) Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 41 : 2275–2280.